[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Viscosupplementation Market (By Procedure – Single Injection, Three Injection & Five Injection; By Region – North America, Europe & Asia Pacific) Outlook 2025

July 2019 | 74 pages | ID: GC6A29973D7EN
Rockville Research

US$ 1,100.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global viscosupplementation market has been witnessing advent of combination therapeutic products, which is already utilized in treatment of various diseases. These products have been relatively new entrants in viscosupplement palliative knee osteoarthritis treatment which offers promising future prospects.

The report “Global Viscosupplementation Market (By Procedure – Single Injection, Three Injection & Five Injection; By Region – North America, Europe & Asia Pacific) Outlook 2025” provides an in-depth analysis of global viscosupplementation market with focus on major procedures Single Injection, Three Injection & Five Injection. Geographical analysis is done across leading markets in regions such as North America, Europe & Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global viscosupplementation market. The report has been segmented as following:-

Geographical Coverage
  • North America - The US
  • Europe
  • Asia Pacific
Key Vendors
  • Sanofi Genzyme
  • Anika Therapeutics, Inc.
  • Seikagaku Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. OSTEOARTHRITIS

3.1 Overview
  3.1.1 Symptoms
  3.1.2 Diagnosis
3.2 Treatment
  3.2.1 Corticosteroids
  3.2.2 Hyaluronic Acid Injections
  3.2.3 Viscosupplementation

4. VISCOSUPPLEMENTATION

4.1 Overview
  4.1.1 Synthesis
4.2 Procedure
  4.2.1 Single Injection
  4.2.2 Three Injection
  4.2.3 Five Injection
4.3 Applications

5. MARKET ANALYSIS

5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share Analysis
  5.2.1 Market Share by Procedure Type
  5.2.2 Market Share by Hyaluronic Acid Type
  5.2.3 Market Share by Application
  5.2.4 Market Share by End-Users
  5.2.5 Market Share by Region

6. MARKET SEGMENTATION – PROCEDURE

6.1 Single injection
  6.1.1 Market Size by Value (Actual & Forecasted)
6.2 Three injection
  6.2.1 Market Size by Value (Actual & Forecasted)
6.3 Five injection
  6.3.1 Market Size by Value (Actual & Forecasted)

7. REGIONAL ANALYSIS

7.1 North America
  7.1.1 Market Sizing (Actual & Forecasted)
  7.1.2 The US
    7.1.2.1 Market Size by Value (Actual & Forecasted)
    7.1.2.2 Market Size by Volume (Actual & Forecasted)
    7.1.2.3 Market Share by Product
7.2 Asia Pacific
  7.2.1 Market Sizing (Actual & Forecasted)
7.3 Europe
  7.3.1 Market Sizing (Actual & Forecasted)

8. MARKET DYNAMICS

8.1 Industry Trends & Developments
  8.1.1 Advent of Combination Therapeutic Products
  8.1.2 Launch of New Products
  8.1.3 Rise in Number of Distribution Agreements
8.2 Growth Drivers
  8.2.1 Increasing Geriatric Population
  8.2.2 Prevalence of Arthritis
  8.2.3 High Demand from Emerging Nations
  8.2.4 Rising Public Awareness
8.3 Challenges
  8.3.1 Stringent Regulations
  8.3.2 Unfavorable Reimbursement Policies
  8.3.3 Adverse Side-Effects

9. COMPETITIVE LANDSCAPE

9.1 Financial Analysis
9.2 Products Portfolio
9.3 Market Share Analysis

10. COMPANY PROFILES

10.1 Sanofi Genzyme
10.2 Anika Therapeutics, Inc.
10.3 Seikagaku Corporation
10.4 Zimmer Biomet Holdings Inc.
10.5 Smith & Nephew Plc


More Publications